The Asia Pacific market for ENT devices will grow at a relatively modest pace through 2027, driven by the increasing adoption of innovative and premium-priced products, such as flexiblescopes, RF handpieces, and powered instruments, along with rising volumes of nose and sinus procedures.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the Asia Pacific region across a 10-year period.
ENT procedure volumes will grow moderately over the forecast period.
Which procedure types will see the greatest growth through 2027? What factors will drive this growth?
What are procedure penetration trends for different procedures?
The market for ENT flexiblescopes, as well as RF and powered instruments will continue to generate a substantial proportion of ENT device market revenues through 2027.
What is driving the adoption of RF and powered instrument devices in the Asia Pacific region?
How will the adoption of flexiblescopes impact rigidscopes sales, if at all?
Most market segments are dominated by MNCs.
Which companies are the leading competitors in these markets?
In which segments do local competitors play a strong role?
- ENT Devices - Market Insights - Asia Pacific
Author(s): Hebri Nandita Mallya
Hebri Nandita Mallya is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in Diagnostic Imaging Systems market. Hebri Nandita Mallya holds a Bachelor's degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master's degree in Medical Biochemistry from Manipal Academy of Higher Education.